Bronchovascular mucormycosis: an urgent surgical problem.
The case of a 70-year-old male with lymphoblastic leukemia is reviewed, who presented the rare and almost always fatal complication of pulmonary mucormycosis, but who was treated satisfactorily with amphotericin B and surgery. The risk of massive hemoptysis in the course of mucormycosis that invades the lung vessels, makes us believe that surgery is an essential part of the management of this disease. It is suggested that the patient be operated as soon as the diagnosis is obtained, as we did in our case, to avoid other risks in combined management with amphotericin B.
Zapatero
J
J
Department of Thoracic Surgery, Hospital Ramón y Cajal, Madrid, Spain.
Flandes
J
J
Ruiz-Zafra
J
J
Fogue
L
L
Salvatierra
S
S
Saldaña
D
D
Peñalver
R
R
Candelas
J
J
D000368:Aged; D000666:Amphotericin B / Q000627:therapeutic use; D001982:Bronchial Diseases / Q000188:drug therapy / Q000276:immunology / Q000601:surgery*; D003131:Combined Modality Therapy; D006801:Humans; D016867:Immunocompromised Host; D008168:Lung / Q000098:blood supply*; D008172:Lung Diseases, Fungal / Q000188:drug therapy / Q000276:immunology / Q000601:surgery*; D008297:Male; D009091:Mucormycosis / Q000188:drug therapy / Q000276:immunology / Q000601:surgery*
D000666:Amphotericin B